Ligand Reports Fourth Quarter and Full Year 2019 Financial Results

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered ...

Verisign Reports Fourth Quarter and Full Year 2019 Results